Alaunos Therapeutics, Inc.·4

Apr 19, 5:00 PM ET

Hofmeister Robert 4

4 · Alaunos Therapeutics, Inc. · Filed Apr 19, 2023

Insider Transaction Report

Form 4
Period: 2023-03-30
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-03-30+150,000150,000 total
    Exercise: $0.66Exp: 2033-03-29Common Stock (150,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2023-03-30+16,66716,667 total
    Exercise: $0.66Exp: 2033-03-29Common Stock (16,667 underlying)
Footnotes (2)
  • [F1]One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from March 30, 2023, with the first vesting occuring on April 30, 2023, subject to the Reporting Person's continued service through each such date.
  • [F2]In equal installments on April 30, 2023 and May 30, 2023, subject to the Reporting Person's continued service through each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION